Labcorp Holdings Inc. LH

309.64 0.69 0.22% as of 25 Sep
Market cap
$21.9B
P/E
25.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Labcorp Holdings Inc. (LH) P/E ratio

As of 25 September 2026, Labcorp Holdings Inc. (LH) trades at a P/E ratio of 25.4×. Over the past ten years it has ranged from 7.4× (December 2018) to 49.5× (January 2024); the current reading is higher than 75% of that period. That is below the Diagnostics & Research industry median of 33.9× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 23.8× (7.72%)
FY2024 25.8× (47.87%)
FY2023 49.5× 237.41%
FY2022 14.7× 33.53%
FY2021 11.0× 0.17%
FY2020 11.0× (36.48%)
FY2019 17.3× 38.49%
FY2018 12.5× 10.76%
FY2017 11.3× (28.45%)
FY2016 15.7× (35.64%)

Quarterly

Period P/E ratio Change
Jun 2026 23.0× (2.04%)
Mar 2026 23.5× (1.33%)
Dec 2025 23.8× (14.93%)
Sep 2025 28.0× (2.58%)
42 more quarters

Against its own ten years

Low 7.4× High 49.5×
Ten-year median 18.5×
Current reading's percentile 75

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on LH